Poland· PL-100329381

Linezolid Kabi

A linezolid product containing linezolidum, registered in Poland by Fresenius Kabi Polska Sp. z o.o.. The same ATC class is registered in 19 of our 19 countries.

ATC J01XX08

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLinezolid KabiATCJ01XX08REGISTER NO.PL-100329381PACKS LISTED6CHECKEDSeptember 27, 2026

Where it is registered

Linezolid is registered in 19 of 19 countries.

Countries holding a registration under ATC J01XX08 (linezolid), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose

Linezolid · ATC J01XX08

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of linezolid costs, country by country.

Normalised to the WHO defined daily dose (1.2 g), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Linezolid · price per daily dose (1.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$125.76
  • IT Italy$109.29
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Linezolidum
Manufacturer
Fresenius Kabi Polska Sp. z o.o.
Country
Poland (PL)
ATC code
J01XX08
ATC class
Linezolid
Defined daily dose
1.2 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

  • gtin
    05909991243050
  • gtin
    05909991216467
  • gtin
    05909991216474
  • gtin
    05909991216481
  • gtin
    05909991243036
  • gtin
    05909991243043

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

393 interactions on record for linezolid.

Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Linezolid · interactions on record

393 records

  • 69 severe
  • 196 moderate
  • 116 info

Most severe, free to view

  • IsomethepteneA03AX10severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe

12 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Linezolid in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All linezolid products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Ilenozyd, Linezolid 1a Pharma
  • Belgium · Linezolid Fresenius Kabi, Linezolid Sandoz
  • Bulgaria · Linezolid Kabi, Линезолид Крка
  • Cyprus · Apel, Linezid
  • Czechia · Linezolid Accord, Linezolid Demo
  • Germany · Linezolid 1 A Pharma, Linezolid Accord
  • Denmark · Linezolid "sandoz", Linezolid Accord
  • Estonia · Apel, Linezolid Accord
  • Spain · Apel, Linezolid Accordpharma
  • Finland · Linezolid Accord, Linezolid Krka
  • France · Linezolide Accord, Linezolide Arrow
  • United Kingdom (Northern Ireland) · Linezolid, Linezolid Accord Healthcare
  • Greece · Antizolid, Linesol
  • Croatia · Linezolid Kabi, Linezolid Krka
  • Hungary · Anozilad, Linesan
  • Ireland · Linezolid, Linezolid Accord Healthcare Ireland
  • Iceland · Zyvoxid
  • Italy · Linezolid Aurobindo, Linezolid Aurobindo Italia
  • Lithuania · Disenil, Linezolid Accord
  • Luxembourg · Linezolid Dr. Eberth, Linezolid Fresenius Kabi
  • Latvia · Apel, Linezolid Accord
  • Malta · Apel, Zyvox
  • Netherlands · Dilizolen, Linezolid Accord
  • Norway · Linezolid Accord, Linezolid Fresenius Kabi
  • Portugal · Linezolida Accord, Linezolida Accordpharma
  • Romania · Linezolid, Linezolid Aurobindo
  • Sweden · Linezolid Accord, Linezolid Glenmark
  • Slovenia · Linezolid Accord, Linezolid Kabi
  • Slovakia · Apel, Linezolid Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f4e1127f-0ded-4b10-a382-fd28c0b520d3
GET /v1/drugs/f4e1127f-0ded-4b10-a382-fd28c0b520d3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do infuzji",
  "source": "urpl",
  "strength": "2 mg/ml",
  "packaging": "05909991216467 ¦ Lz ¦ 107805\n10 worków  po 300 ml\n05909991216474 ¦ Lz ¦ 107806\n30 worków  po 300 ml\n05909991216481 ¦ Lz ¦ 107807\n50 worków  po 300 ml\n05909991243036 ¦ Lz ¦ 111603\n10 butelek  po 300 ml\n05909991243043 ¦ Lz ¦ 111604\n30 butelek  po 300 ml\n05909991243050 ¦ Lz ¦ 111605\n50 butelek  po 300 ml",
  "substance": "Linezolidum 2 mg/ml",
  "common_name": "Linezolidum",
  "pl_product_id": "100329381",
  "pozwolenie_nr": "22370",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about linezolid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.